IEX · 8-K · 20261028PR000026
Guidance / Outlook
IDEX CORP /DE/ · 2026-10-28 · Importance 61 · Surprise 76 · In source text
IDEX raised its full-year 2026 organic sales growth projection to 6.5%–6.8%, from prior guidance of 5%–6%. It increased its adjusted diluted EPS outlook to $8.91–$8.96, from $8.70–$8.85. The revised EPS range represents approximately 12% year-over-year growth at the midpoint.
Key facts
- IDEX raised full-year adjusted diluted EPS guidance to $8.91–$8.96, approximately 12% year-over-year growth at the midpoint, from prior guidance of $8.70–$8.85. source
- IDEX raised its full-year organic sales growth outlook to 6.5%–6.8%, from prior guidance of 5%–6%. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | positive | committed | — | IDEX raised full-year adjusted diluted EPS guidance to $8.91–$8.96, approximately 12% year-over-year growth at the midpoint, from prior… |
| revenue | positive | committed | — | IDEX raised its full-year organic sales growth outlook to 6.5%–6.8%, from prior guidance of 5%–6%. |